Über Michelson Diagnostics
A passion for healthier skin and happier lives
Unsere Mission
Bei Michelson Diagnostics verfolgen wir
ein einziges Ziel:
To empower clinicians and researchers with revolutionary skin imaging that improves skin health and enhances patient outcomes. Our advanced Optical Coherence Tomography (OCT) technology delivers high-resolution, real- time imaging beneath the skin’s surface — giving users The Whole Picture® of what’s happening below.
Wer wir sind
Michelson Diagnostics hat seinen Sitz in Kent im Süden des Vereinigten Königreichs.
Founded in March 2006 by a team of physicists and engineers, it has pioneered the practical application of OCT in dermatology and skin research. Since then, our evolving VivoSight product line has been widely adopted by clinical users and research centres in Europe, USA, Asia and Australia. To date it has been used to perform over 200,000 patient scans, and has been cited in over 800 peer- reviewed publications, reflecting its scientific credentials and clinical impact.
We believe OCT skin imaging has transformative potential — helping clinicians make better, more informed decisions without invasive procedures, and enabling researchers to gain deeper insights into skin structure and pathology. Our purpose is to expand access to meaningful, cost-effective OCT solutions that support everyday clinical and research needs.
Was wir tun
Unser OCT-System der nächsten Generation, VivoSight Dx Pro, liefert nicht-invasive, hochauflösende 3D-Bildgebung der Hautmikrostruktur und Gefäßversorgung.
It offers unmatched depth and field-of-view, helping dermatologists, clinicians, and research professionals visualize and quantify subtle changes beneath the skin’s surface that other imaging methods cannot reveal. The addition of artificial intelligence in VivoSight Dx Pro makes clinical diagnostic scanning easier and faster to use, making this truly accessible to every dermatologists.
In the USA, customer sales and service is managed through Michelson Diagnostics Inc, based in California; and we have a growing network of distributors, growing and supporting our clinical and research markets around the world.
Lernen Sie das Managementteam kennen
-
Jon Holmes
CEO & Co-Founder
Jon brings over 30 years of engineering expertise to steer Michelson Diagnostics’ vision and technology development. Before co-founding Michelson Diagnostics, Jon held leadership roles in biomedical engineering and has authored patents and publications in OCT.
-
Alison Day
Financial Controller, Operations Manager
With more than three decades of experience in accounting and operational management, Alison ensures the company’s financial strength, operational excellence, and quality delivery across functions.
Vorstand
-
Kevin D’Silva
Vorsitzender
-
Jon Holmes
Direktor
-
Xavier Yon
Nicht-geschäftsführender Direktor